Ramanathan RK, Stephenson JJ, Weiss GJ, Pestano LA, Lowe A, Hiscox A, et al
Department of Veterans Affairs database found that GLP-1RA therapy reduced the risk of dementia and AD by 8% and 12%, respectively (Xie et al., 2025)
After injection, it binds to GLP-1 receptors in the body and performs several important actions simultaneously: 1
This can help reduce unwanted body weight and improve energy/power output
Due to high stability and high exposures, these parameters suggested the potential for once-weekly administration of MC4-NN2-0453
an effect that reached statistical significance with the 10 and 25 nmol/kg doses (Fig